Therapeutic research for depression and insomnia. [IDrugs. 2008] - PubMed

loading

Insomnia market. [Nat Rev Drug Discov. 2006]
Insomnia market.
Gershell L. Nat Rev Drug Discov. 2006 Jan; 5(1):15-6.
Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. [Curr Opin Investig Drugs. 2009]
Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Hardeland R. Curr Opin Investig Drugs. 2009 Jul; 10(7):691-701.
Review CEE-03-310 CeNeS pharmaceuticals. [Curr Opin Investig Drugs. 2002]
Review CEE-03-310 CeNeS pharmaceuticals.
Eder DN. Curr Opin Investig Drugs. 2002 Feb; 3(2):284-8.
Pain management--Visiongain's fourth annual conference. Exploring recent developments in pain therapy. [IDrugs. 2008]
Pain management--Visiongain's fourth annual conference. Exploring recent developments in pain therapy.
Jain K. IDrugs. 2008 Jan; 11(1):27-9.
Review Insomnia in patients with depression: some pathophysiological and treatment considerations. [CNS Drugs. 2009]
Review Insomnia in patients with depression: some pathophysiological and treatment considerations.
Jindal RD. CNS Drugs. 2009; 23(4):309-29.

Therapeutic research for depression and insomnia.
Therapeutic research for depression and insomnia.
IDrugs. 2008 Jan ;11(1):10-2.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed